Sven Henrichwark

Sven Henrichwark

Voorzitter bij
Fibronostics US, Inc.
60 jaar
Health Technology
Finance
Technology Services

Profiel

Sven Henrichwark currently works at Fibronostics US, Inc., as Chairman & President from 2020, Medera, Inc., as Independent Director, Kyberlife Pte Ltd, as Director, and Ampersand Management LLC, as Operating Partner & Executive Advisor from 2022.
Dr. Henrichwark also formerly worked at Echosens SA, as Chief Executive Officer from 2018 to 2019, GE Life Science & Technology Finance, as General Manager, GE Healthcare, Inc., as General Manager-Business Operations & Service, and Avantor, Inc., as Executive Vice President-Asia Pacific Region.
Dr. Henrichwark received his doctorate degree from Pasteur Institute.

Actieve functies van Sven Henrichwark

BedrijvenFunctieBegin
Voorzitter 01-07-2024
Private Equity Investor 01-01-2022
Directeur/Bestuurslid -

Eerdere bekende functies van Sven Henrichwark

BedrijvenFunctieEinde
Algemeen Directeur 14-08-2019
Corporate Officer/Principal -
Corporate Officer/Principal -
AVANTOR, INC. Corporate Officer/Principal -
Ervaring van Sven Henrichwark in detail bekijken

Opleiding van Sven Henrichwark

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

11

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Finance

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

  1. Beurs
  2. Insiders
  3. Sven Henrichwark